MarketScreener Editorial Features Opiant Pharmaceuticals, Inc.
Equities
OPNT
US6837501039
MarketScreener Editorial Features
MarketScreener's World Press Review : November 14, 2022 | November 14, 2022 at 11:23 am EST |
MarketScreener's World Press Review : November 14, 2022 | November 14, 2022 at 11:23 am EST |